Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT00220740 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

DRUG: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified
DRUG: Albumin (Human) 25%, United States Pharmacopeia (USP)

Sponsor

Grifols Therapeutics LLC